Acne Vulgaris Relapse in Sudanese Patients Treated with Oral Isotretinoin: Rate and Predictive Factors.

Shimaa IbrahimBashier OsmanReela M AwaadIman Hassan Abdoon

Published in: Journal of multidisciplinary healthcare (2023)

About one-third of patients experienced acne relapse. Early discontinuation and low cumulative doses of OI are the main risk factors for acne relapse. Long-term therapy of OI, with cumulative doses of 120-159 mg/kg, would be beneficial to reduce acne relapse.

Keyphrases

free survival
hidradenitis suppurativa
end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
stem cells
patient reported outcomes
bone marrow